insights_auto
Por qué ha bajado MANKIND 3,07%?
Profundizarchevron_right
MANKIND:NSE
Mankind Pharma Ltd
2.275,50 INR
arrow_downward
-3,07%(-72,10) 1 d
16 oct, 15:30:00 GMT+5:30 · INR
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de MANKIND...
Abrir
2.349,90 INR
Alto
2.354,40 INR
Bajo
2.268,70 INR
Cap. burs.
937,40 mil M
Vol. medio
483,95 mil
Volumen
889,73 mil
Ratio PER
46,04
Máximo en 52 sem.
2.642,00 INR
Mínimo en 52 sem.
1.909,70 INR
BPA
49,42 INR
N.º de empleados
20 mil
Abrir
2.349,90 INR
Alto
2.354,40 INR
Bajo
2.268,70 INR
Cap. burs.
937,40 mil M
Vol. medio
483,95 mil
Volumen
889,73 mil
Ratio PER
46,04
Máximo en 52 sem.
2.642,00 INR
Mínimo en 52 sem.
1.909,70 INR
BPA
49,42 INR
N.º de empleados
20 mil
Noticias
De fuentes web y partners de noticias
The Pharma Letter
·
hace 38 minutos
Lakefront sells CAR-T programs as Mankind agrees Armed Cell investment
Perfil
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Acerca de Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Empleados20,5 mil
Fundación1991
Sede-
Sector-
Sitio webmankindpharma.com